{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/08/28/3352748/0/en/crispr-therapeutics-presents-phase-1a-data-for-ctx310-demonstrating-deep-and-durable-angptl3-editing-triglyceride-and-ldl-lowering-at-esc-congress-2026.html", "message": "News view counter 907358 successfully enlarged"}